2Lebwohl M. Psoriasis[J]. Lancet, 2003, 361: 1197-1204.
3OdomRB, JamesWD, BergerTG. Andrews' diseases of the skin[M].9th ed. Singapore: Harcourt Asia,2000.218-235.
4Yosipoviteh G, Tang MB. Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options[J]. Drugs Aging,2002,19:847-863.
5Kawamura A, Ochiai T. Candesartan cilexetil induced pustular psoriasis [J]. Eur J Dermatol,2003,13:406-407.
6Leman J, Burden D. Psoriasis in children: a guide to its diagnosis and management [ J]. Paediatr Drugs,2001,3:673-680.
7Mafong EA, Friedman PM, Kauvar AN, etal. Treament ofinverse psoriasis with the 308 nm excimer laser[J]. Dermatol Surg, 2002, 28:530-532.
8Karvonen J. HL-A antigens in psoriasis with special reference to the clinical type,age of onset,exacerbations after respiratory infections and occurrence of arthritis[J].ANNALS OF CLINICAL RESEARCH,1975,(05):301-311.
9WHPM Vissers,Roelofzen J,EMGJ De Jong. Flexural versus plaque lesions in psoriasis:an immunohistoehemical differentiation[J].Euro J Dermatol,2005,(01):7-13.
10Zanchi M,Favot F,Bizzarini M. Botulinum toxin type-A for the treatment of inverse psoriasis[J].Journal of the European Academy of Dermatology and Venereology,2008,(04):431-436.
